pyridostigmine bromide has been researched along with Idiopathic Parkinson Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Ha, S; Kim, J; Kim, SH; Kim, WJ; Kwon, HM; Moon, YJ; Park, HS; Park, YS | 1 |
| Ansari, Y; Chung, KA; Gibbons, CH; Helfand, M; Peterson, K; Raj, SR; Veazie, S | 1 |
| Castro Caldas, A; Ferreira, JJ; Simões, RM | 1 |
| Baumann, CR; Büchele, F; Kägi, G; Schreglmann, SR | 1 |
| Biaggioni, I; Jordan, J; Shibao, C | 1 |
| Baumann, CR; Büchele, F; Epprecht, L; Götze, O; Hägele-Link, S; Kägi, G; Schreglmann, SR; Sommerauer, M; Waldvogel, D; Zimmerli, L | 1 |
| Korucuk, M; Sener, U; Uludag, IF; Zorlu, Y | 1 |
| Abramsky, O; Karussis, D; Levin, N | 1 |
| Bentivoglio, AR; Evoli, A; Fasano, A; Piano, C; Tonali, PA | 1 |
| Sadjadpour, K | 1 |
| Chang, YC; Kao, KP; Kwan, SY; Lin, KP | 1 |
| Gilbert, JC | 1 |
| Stern, FH | 1 |
1 review(s) available for pyridostigmine bromide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Fludrocortisone for orthostatic hypotension.
Topics: Bias; Diabetes Mellitus; Domperidone; Dysautonomia, Familial; Fludrocortisone; Humans; Hypotension, Orthostatic; Observational Studies as Topic; Parkinson Disease; Pyridostigmine Bromide; Randomized Controlled Trials as Topic | 2021 |
1 trial(s) available for pyridostigmine bromide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
Topics: Aged; Blood Pressure; Cholinesterase Inhibitors; Cross-Over Studies; Double-Blind Method; Female; Fludrocortisone; Humans; Hypotension, Orthostatic; Male; Middle Aged; Parkinson Disease; Pyridostigmine Bromide; Quality of Life; Risk Factors; Treatment Outcome | 2017 |
11 other study(ies) available for pyridostigmine bromide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Comparison of recovery profiles in patients with Parkinson's disease for 2 types of neuromuscular blockade reversal agent following deep brain stimulator implantation.
Topics: Anesthesia Recovery Period; Cholinesterase Inhibitors; Deep Brain Stimulation; Electrodes, Implanted; Female; Humans; Male; Middle Aged; Neuromuscular Blockade; Parkinson Disease; Prosthesis Implantation; Pyridostigmine Bromide; Retrospective Studies; Sugammadex | 2019 |
Comments on: 'Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial'.
Topics: Blood Pressure; Cholinesterase Inhibitors; Fludrocortisone; Humans; Hypotension, Orthostatic; Parkinson Disease; Pyridostigmine Bromide | 2018 |
Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - reply.
Topics: Blood Pressure; Cholinesterase Inhibitors; Fludrocortisone; Humans; Hypotension, Orthostatic; Parkinson Disease; Pyridostigmine Bromide | 2018 |
Multiple system atrophy: using clinical pharmacology to reveal pathophysiology.
Topics: Atomoxetine Hydrochloride; Autonomic Nervous System; Clonidine; Diagnosis, Differential; Drug Therapy; Humans; Indole Alkaloids; Multiple System Atrophy; Parkinson Disease; Pure Autonomic Failure; Pyridostigmine Bromide; Trimethaphan | 2015 |
Myasthenia gravis as a cause of head drop in Parkinson disease.
Topics: Aged; Cholinesterase Inhibitors; Electromyography; Head; Humans; Immunoglobulins, Intravenous; Male; Muscle Weakness; Myasthenia Gravis; Neck Muscles; Parkinson Disease; Pyridostigmine Bromide | 2011 |
Parkinson's disease associated with myasthenia gravis. A report of 4 cases.
Topics: Aged; Azathioprine; Cholinesterase Inhibitors; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Parkinson Disease; Prevalence; Pyridostigmine Bromide; Receptors, Cholinergic | 2003 |
Myasthenia gravis: an unrecognized cause of head drop in Parkinson's disease.
Topics: Anti-Inflammatory Agents; Antiparkinson Agents; Cholinesterase Inhibitors; Electromyography; Female; Head Movements; Humans; Middle Aged; Movement Disorders; Myasthenia Gravis; Parkinson Disease; Plasma Exchange; Prednisone; Pyridostigmine Bromide; Spinal Osteophytosis | 2008 |
Pyridostigmine bromide and constipation in Parkinson's disease.
Topics: Constipation; Humans; Parkinson Disease; Pyridostigmine Bromide | 1983 |
Coexistence of Parkinson's disease and myasthenia gravis: a case report.
Topics: Brain; Cholinesterase Inhibitors; Female; Humans; Middle Aged; Myasthenia Gravis; Parkinson Disease; Prednisolone; Pyridostigmine Bromide; Trihexyphenidyl | 1993 |
Diseases of the central nervous system. Pharmacological basis of treatment.
Topics: Amantadine; Analgesics, Opioid; Anticonvulsants; Blood-Brain Barrier; Central Nervous System Diseases; Cholinesterase Inhibitors; Edrophonium; Epilepsy; Headache; Humans; Levodopa; Methysergide; Migraine Disorders; Myasthenia Gravis; Parkinson Disease; Pyridostigmine Bromide; Serotonin Antagonists | 1975 |
Myasthenia gravis, an often overlooked disease in the geriatric group.
Topics: Adrenal Insufficiency; Aged; Amyotrophic Lateral Sclerosis; Chronic Disease; Curare; Diagnosis, Differential; Female; Humans; Hypothyroidism; Male; Muscular Diseases; Myasthenia Gravis; Neostigmine; Paralyses, Familial Periodic; Parkinson Disease; Pyridostigmine Bromide | 1966 |